2013
DOI: 10.1016/j.ijrobp.2013.06.254
|View full text |Cite
|
Sign up to set email alerts
|

Deletion of the Tumor Suppressor NFKBIA in Triple-Negative Breast Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Mutations have been widely reported to contribute to specific functional alteration of crucial proteins including NFKBIA in diseases especially in various cancer subtypes like pancreatic cancer [ 38 41 ]. What is more, as one of the crucial inhibitory components of NF-kappa-B pathway, NFKBIA has been reported to be downregulated in cancer [ 42 , 43 ]. The overexpression of NFKBIA has also been reported to be associated with a better prognosis of various treatment methods in different human tumor subtypes, especially for the prognosis of patients that have taken alpha 1-adrenoceptor antagonists and radiotherapy [ 44 , 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…Mutations have been widely reported to contribute to specific functional alteration of crucial proteins including NFKBIA in diseases especially in various cancer subtypes like pancreatic cancer [ 38 41 ]. What is more, as one of the crucial inhibitory components of NF-kappa-B pathway, NFKBIA has been reported to be downregulated in cancer [ 42 , 43 ]. The overexpression of NFKBIA has also been reported to be associated with a better prognosis of various treatment methods in different human tumor subtypes, especially for the prognosis of patients that have taken alpha 1-adrenoceptor antagonists and radiotherapy [ 44 , 45 ].…”
Section: Resultsmentioning
confidence: 99%
“…NFkB is constitutively activated in ER−negative and TN breast tumors, mediates adaptive resistance to ionizing radiation and chemotherapy, and is required for epithelial–mesenchymal transition (EMT) associated with metastatic progression of BC. NFKBIA deletions, leading to a haploinsufficient effect on NFKBIA expression and thus the transactivation of several NFkB target genes with important roles in TN breast carcinogenesis, are significantly associated with TN patients [35]. hsa-miR-423-5p has been observed to be upregulated in drug-resistant BC cells from the parental MDA-MB-231 cell line [36].…”
Section: Discussionmentioning
confidence: 99%